Deleuran, M., Marcoux, D., De Bruin-Weller, M. S., Irvine, A. D., Baselga, E., Ahn, K., … Rossi, A. B. (2021). Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use. Acta Dermato-Venereologica, 101(7), adv00504. https://doi.org/10.2340/00015555-3848